Wellbiotec Past Earnings Performance
Past criteria checks 0/6
Wellbiotec's earnings have been declining at an average annual rate of -21.5%, while the Luxury industry saw earnings growing at 19% annually. Revenues have been growing at an average rate of 11.3% per year.
Key information
-21.5%
Earnings growth rate
-4.1%
EPS growth rate
Luxury Industry Growth | 21.6% |
Revenue growth rate | 11.3% |
Return on equity | -192.5% |
Net Margin | -91.3% |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Wellbiotec makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 72,787 | -66,441 | 29,720 | 0 |
31 Dec 23 | 72,132 | -64,976 | 28,355 | 0 |
30 Sep 23 | 67,868 | -22,517 | 18,054 | 0 |
30 Jun 23 | 89,410 | -23,287 | 18,247 | 0 |
31 Mar 23 | 115,689 | -25,077 | 18,575 | 0 |
31 Dec 22 | 158,116 | -20,881 | 19,761 | 0 |
30 Sep 22 | 157,959 | -25,953 | 13,275 | 97 |
30 Jun 22 | 164,626 | -23,422 | 13,939 | 147 |
31 Mar 22 | 153,331 | -29,099 | 12,986 | 186 |
31 Dec 21 | 108,377 | -34,861 | 11,937 | 186 |
30 Sep 21 | 107,138 | -24,727 | 9,161 | 89 |
30 Jun 21 | 75,149 | -31,380 | 13,266 | 64 |
31 Mar 21 | 59,256 | -50,769 | 15,211 | 28 |
31 Dec 20 | 60,431 | -50,513 | 17,523 | 42 |
30 Sep 20 | 58,699 | -34,163 | 23,887 | 61 |
30 Jun 20 | 57,809 | -28,582 | 18,884 | 39 |
31 Mar 20 | 53,086 | -7,917 | 16,528 | 36 |
31 Dec 19 | 52,333 | -4,333 | 14,043 | 22 |
30 Sep 19 | 74,363 | -9,321 | 15,291 | -13 |
30 Jun 19 | 74,922 | -11,345 | 13,971 | -3 |
31 Mar 19 | 74,007 | -11,436 | 12,979 | -1 |
31 Dec 18 | 73,932 | -13,754 | 12,098 | 0 |
30 Sep 18 | 75,574 | -15,466 | 10,401 | 16 |
30 Jun 18 | 71,854 | -12,032 | 9,124 | 3 |
31 Mar 18 | 72,043 | -8,018 | 8,322 | 1 |
31 Dec 17 | 70,786 | -8,742 | 7,776 | 0 |
30 Sep 17 | 73,822 | -2,944 | 7,846 | 0 |
30 Jun 17 | 79,188 | -4,797 | 8,037 | 0 |
31 Mar 17 | 80,912 | -4,502 | 8,113 | 0 |
31 Dec 16 | 85,292 | -2,450 | 8,252 | 0 |
30 Sep 16 | 93,394 | -2,163 | 8,188 | 0 |
30 Jun 16 | 98,733 | -135 | 8,217 | 0 |
31 Mar 16 | 105,336 | 766 | 8,465 | 0 |
31 Dec 15 | 112,488 | 550 | 8,464 | 0 |
30 Sep 15 | 115,378 | -5,577 | 9,334 | 0 |
30 Jun 15 | 116,840 | -5,579 | 9,443 | 0 |
31 Mar 15 | 115,684 | -7,697 | 9,258 | 0 |
31 Dec 14 | 119,630 | -6,655 | 9,525 | 0 |
30 Sep 14 | 124,935 | 468 | 9,041 | 0 |
30 Jun 14 | 132,289 | 171 | 9,366 | 0 |
31 Mar 14 | 140,576 | 3,251 | 10,124 | 0 |
31 Dec 13 | 137,762 | 2,374 | 11,392 | 0 |
30 Sep 13 | 135,353 | 734 | 11,879 | 0 |
Quality Earnings: A010600 is currently unprofitable.
Growing Profit Margin: A010600 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A010600 is unprofitable, and losses have increased over the past 5 years at a rate of 21.5% per year.
Accelerating Growth: Unable to compare A010600's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A010600 is unprofitable, making it difficult to compare its past year earnings growth to the Luxury industry (-29.2%).
Return on Equity
High ROE: A010600 has a negative Return on Equity (-192.52%), as it is currently unprofitable.